Cycloferon for Post-exposure Prophylaxis of Acute Respiratory Viral Infections and Influenza

Clinical trial NCT06183229 · COMPLETED

Trial details

NCT number: NCT06183229
Sponsor: POLYSAN Scientific & Technological Pharmaceutical Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Influenza Acute Respiratory Infection

Start date: 2023-09-15
Primary completion: 2024-03-01
Enrollment: 166

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.